Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Taylor Swift Just Gave Some of the Best Advice You’ll Ever Hear, and It All Comes Down to a Simple Mindset Shift ...

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Eli Lilly is doubling down on its partnership with Chinese tech outfit XtalPi, striking a new antibody development pact that ...

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales growth that’s driving its battle for the obesity startup Metsera.

New blood tests could help doctors diagnose Alzheimer's disease faster and more accurately, researchers reported Sunday – but ...

The menopausal transition is a pivotal time in women’s health, bringing about profound hormonal, metabolic and physiologic ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

The field of oncology has been profoundly impacted by malignant solid tumours, representing a significant challenge in healthcare. While strides have been ...